| Diketopyrrolopyrrole-based semiconducting polymer nanoparticles for in vivo photoacoustic imaging K Pu, J Mei, JV Jokerst, G Hong, AL Antaris, N Chattopadhyay, ... Advanced materials (Deerfield Beach, Fla.) 27 (35), 5184, 2015 | 328 | 2015 |
| Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location E Lechtman, N Chattopadhyay, Z Cai, S Mashouf, R Reilly, JP Pignol Physics in Medicine & Biology 56 (15), 4631, 2011 | 304 | 2011 |
| Nanotechnology applications for improved delivery of antiretroviral drugs to the brain HL Wong, N Chattopadhyay, XY Wu, R Bendayan Advanced drug delivery reviews 62 (4-5), 503-517, 2010 | 261 | 2010 |
| Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line N Chattopadhyay, J Zastre, HL Wong, XY Wu, R Bendayan Pharmaceutical research 25, 2262-2271, 2008 | 222 | 2008 |
| Recent advances of semiconducting polymer nanoparticles in in vivo molecular imaging K Pu, N Chattopadhyay, J Rao Journal of Controlled Release 240, 312-322, 2016 | 200 | 2016 |
| Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation N Chattopadhyay, Z Cai, YL Kwon, E Lechtman, JP Pignol, RM Reilly Breast cancer research and treatment 137, 81-91, 2013 | 184 | 2013 |
| A Monte Carlo-based model of gold nanoparticle radiosensitization accounting for increased radiobiological effectiveness E Lechtman, S Mashouf, N Chattopadhyay, BM Keller, P Lai, Z Cai, ... Physics in Medicine & Biology 58 (10), 3075, 2013 | 169 | 2013 |
| Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer N Chattopadhyay, Z Cai, JP Pignol, B Keller, E Lechtman, R Bendayan, ... Molecular pharmaceutics 7 (6), 2194-2206, 2010 | 139 | 2010 |
| Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual counting Z Cai, N Chattopadhyay, WJ Liu, C Chan, JP Pignol, RM Reilly International journal of radiation biology 87 (11), 1135-1146, 2011 | 133 | 2011 |
| Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo N Chattopadhyay, H Fonge, Z Cai, D Scollard, E Lechtman, SJ Done, ... Molecular pharmaceutics 9 (8), 2168-2179, 2012 | 111 | 2012 |
| 111In-labeled trastuzumab-modified gold nanoparticles are cytotoxic in vitro to HER2-positive breast cancer cells and arrest tumor growth in vivo in athymic mice after … Z Cai, N Chattopadhyay, K Yang, YL Kwon, S Yook, JP Pignol, RM Reilly Nuclear medicine and biology 43 (12), 818-826, 2016 | 78 | 2016 |
| Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation Z Cai, JP Pignol, N Chattopadhyay, YL Kwon, E Lechtman, RM Reilly Medical physics 40 (11), 114101, 2013 | 41 | 2013 |
| CYP3A4‐mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1‐mediated effects on bilirubin glucuronidation in humans N Chattopadhyay, T Kanacher, M Casjens, S Frechen, S Ligges, ... British Journal of Clinical Pharmacology 84 (12), 2857-2866, 2018 | 21 | 2018 |
| Diketopyrrolopyrrole-Based Semiconducting Polymer Nanoparticles for K Pu, J Mei, JV Jokerst, G Hong, AL Antaris, N Chattopadhyay, ... Vivo, 2015 | 16 | 2015 |
| Effect of hepatic impairment on the pharmacokinetics of vilaprisan: an open‐label, single‐dose, parallel‐group study N Chattopadhyay, K Riecke, S Ligges, T Zimmermann, A Halabi, ... British Journal of Clinical Pharmacology 85 (9), 2011-2021, 2019 | 7 | 2019 |
| Preclinical and clinical pharmacokinetics and bioavailability in healthy volunteers of a novel formulation of the selective P2X3 receptor antagonist eliapixant K Francke, N Chattopadhyay, S Klein, A Rottmann, D Krickau, ... European Journal of Drug Metabolism and Pharmacokinetics 48 (1), 75-87, 2023 | 2 | 2023 |
| EFFECT OF HEPATIC AND RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF COPANLISIB. C Granvil, N Chattopadhyay, A Kohnke, G Cisternas, M Gurniak, M Wang, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S13-S13, 2021 | 1 | 2021 |
| Development, Characterization and Validation of Trastuzumab-Modified Gold Nanoparticles for Molecularly Targeted Radiosensitization of Breast Cance N Chattopadhyay | 1 | 2012 |
| Gold Nanoparticle Radiosensitization: Optimizing Photon Energy, Nanoparticle Size, and Location for Clinical Translation E Lechtman, N Chattopadhyay, S Mashouf, Z Cai, R Reilly, J Pignol International Journal of Radiation Oncology, Biology, Physics 81 (2), S740, 2011 | 1 | 2011 |
| Gold Nanoparticle radiosensitization is most efficient in the brachytherapy energy range E Lechtman, JP Pignol, B Keller, A Ravi, N Chattopadhyay, Z Cai, R Reilly Brachytherapy 9, S46-S47, 2010 | 1 | 2010 |
